Literature DB >> 21937739

Evidence of oncogene-induced senescence in thyroid carcinogenesis.

Maria Grazia Vizioli1, Patricia A Possik, Eva Tarantino, Katrin Meissl, Maria Grazia Borrello, Claudia Miranda, Maria Chiara Anania, Sonia Pagliardini, Ettore Seregni, Marco A Pierotti, Silvana Pilotti, Daniel S Peeper, Angela Greco.   

Abstract

Oncogene-induced senescence (OIS) is a growth arrest triggered by the enforced expression of cancer-promoting genes and acts as a barrier against malignant transformation in vivo. In this study, by a combination of in vitro and in vivo approaches, we investigate the role of OIS in tumours originating from the thyroid epithelium. We found that expression of different thyroid tumour-associated oncogenes in primary human thyrocytes triggers senescence, as demonstrated by the presence of OIS hallmarks: changes in cell morphology, accumulation of SA-β-Gal and senescence-associated heterochromatic foci, and upregulation of transcription of the cyclin-dependent kinase inhibitors p16(INK4a) and p21(CIP1). Furthermore, immunohistochemical analysis of a panel of thyroid tumours characterised by different aggressiveness showed that the expression of OIS markers such as p16(INK4a), p21(CIP1) and IGFBP7 is upregulated at early stages, and lost during thyroid tumour progression. Taken together, our results suggest a role of OIS in thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937739     DOI: 10.1530/ERC-11-0240

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  17 in total

Review 1.  BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma.

Authors:  F I Moulana; A A H Priyani; M V C de Silva; R S Dassanayake
Journal:  Horm Cancer       Date:  2017-12-05       Impact factor: 3.869

2.  Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.

Authors:  Roberto Bellelli; Donata Vitagliano; Giorgia Federico; Pina Marotta; Anna Tamburrino; Paolo Salerno; Orlando Paciello; Serenella Papparella; Jeffrey A Knauf; James A Fagin; Samuel Refetoff; Giancarlo Troncone; Massimo Santoro
Journal:  Mol Cell Endocrinol       Date:  2017-06-23       Impact factor: 4.102

3.  Inflammation in thyroid oncogenesis.

Authors:  Federica Liotti; Carla Visciano; Rosa Marina Melillo
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

4.  Increased expression of oncogene-induced senescence markers during cervical squamous cell cancer development.

Authors:  Yongsheng Zhang; Liangsheng Guo; Pengfei Xing; Yuanyuan Chen; Feng Li; Weipei Zhu; Xueguan Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 5.  Central role of RET in thyroid cancer.

Authors:  Massimo Santoro; Francesca Carlomagno
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

6.  Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Authors:  Lusia Sepiashvili; Angela Hui; Vladimir Ignatchenko; Willa Shi; Susie Su; Wei Xu; Shao Hui Huang; Brian O'Sullivan; John Waldron; Jonathan C Irish; Bayardo Perez-Ordonez; Fei-Fei Liu; Thomas Kislinger
Journal:  Mol Cell Proteomics       Date:  2012-08-23       Impact factor: 5.911

Review 7.  Two-Step Senescence-Focused Cancer Therapies.

Authors:  Cynthia J Sieben; Ines Sturmlechner; Bart van de Sluis; Jan M van Deursen
Journal:  Trends Cell Biol       Date:  2018-05-17       Impact factor: 20.808

8.  TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer.

Authors:  M Zou; E Y Baitei; R A Al-Rijjal; R S Parhar; F A Al-Mohanna; S Kimura; C Pritchard; H A Binessa; A S Alzahrani; H H Al-Khalaf; A Hawwari; M Akhtar; A M Assiri; B F Meyer; Y Shi
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

9.  Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.

Authors:  Maria Grazia Vizioli; Joana Santos; Silvana Pilotti; Mara Mazzoni; Maria Chiara Anania; Claudia Miranda; Sonia Pagliardini; Marco A Pierotti; Jesus Gil; Angela Greco
Journal:  Oncotarget       Date:  2014-09-30

10.  TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcinogenesis through regulation of DUSP6.

Authors:  Young Hwa Kim; Yong Won Choi; Jae Ho Han; Jeonghun Lee; Euy Young Soh; So Hyun Park; Jang-Hee Kim; Tae Jun Park
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.